Back to search

Article

Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentration

2024-07-08

Abstract excerpt

<h4>Objective</h4> To correlate rpoB mutations found on the sanger sequencing in Mycobacterium tuberculosis (MTB) isolates with Minimum Inhibitory Concentrations (MICs) to the rifampicin. <h4>Methods</h4> We assessed the minimum inhibitory concentrations (MICs) for 151 archived clinical MTB isolates that were determined phenotypically susceptible to RIF (101;66.89%) and remaining fifty (50;33.11%) were resist...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4a6a4f5f-2d24-5231-8c01-087e4e66dd16
DOI
10.1101/2024.07.08.602571
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentrationDOI 10.1101/2024.07.08.602571
Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicinSemantic proximity
Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes.Semantic proximity
Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.Semantic proximity
Rifampicin and rifabutin resistance in 1000 <i>Mycobacterium tuberculosis</i> clinical isolatesSemantic proximity
The ins and outs of Mycobacterium tuberculosis drug susceptibility testing.Semantic proximity
Determination of Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Para-Aminosalicylic Acid with clinical isolates with thyA, folC and dfrA mutationsSemantic proximity
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania.Semantic proximity
Current drug susceptibility testing in the Löwenstein-Jensen medium leads to underestimating of prothionamide resistance in multi-drug resistant Mycobacterium tuberculosis.Semantic proximity
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.Semantic proximity
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific <i>rpoB</i> MutationsSemantic proximity
rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment OutcomesSemantic proximity
Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022.Semantic proximity
Select a neighboring publication to make it the new centre.